| Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
MYD88 innate immune signal transduction adaptor | 0.414 | 0.923 | 0.12 |
|
phenotype | 0.010 | None | < 0.001 | 1 | 1 | 2018 | 2018 | ||||||||
|
platelet derived growth factor receptor beta | 0.416 | 0.846 | 0.90 |
|
phenotype | 0.010 | None | < 0.001 | 1 | 0 | 2016 | 2016 | ||||||||
|
upstream transcription factor 2, c-fos interacting | 0.626 | 0.654 | 0.99 |
|
phenotype | 0.010 | None | < 0.001 | 1 | 0 | 1996 | 1996 | ||||||||
|
alpha-methylacyl-CoA racemase | 0.510 | 0.769 | 2.7E-02 |
|
phenotype | 0.010 | None | < 0.001 | 1 | 0 | 1996 | 1996 | ||||||||
|
NADH:ubiquinone oxidoreductase subunit S4 | 0.587 | 0.808 | 3.1E-04 |
|
phenotype | 0.010 | None | < 0.001 | 1 | 0 | 2017 | 2017 | ||||||||
|
T cell receptor delta joining 1 | 0.736 | 0.269 |
|
phenotype | 0.030 | None | 0.667 | 3 | 0 | 1999 | 2003 | |||||||||
|
T cell receptor delta constant | 0.729 | 0.269 |
|
phenotype | 0.030 | None | 0.667 | 3 | 0 | 1999 | 2003 | |||||||||
|
T cell receptor delta locus | 0.650 | 0.692 |
|
phenotype | 0.030 | None | 0.667 | 3 | 0 | 1999 | 2003 | |||||||||
|
T cell receptor delta diversity 3 | 0.736 | 0.269 |
|
phenotype | 0.030 | None | 0.667 | 3 | 0 | 1999 | 2003 | |||||||||
|
cytokine receptor like factor 2 | 0.615 | 0.538 | 3.3E-07 |
|
phenotype | 0.040 | None | 0.750 | 4 | 1 | 2012 | 2018 | ||||||||
|
immunoglobulin kappa locus | 0.647 | 0.462 |
|
phenotype | 0.060 | None | 0.833 | 6 | 0 | 1998 | 2017 | |||||||||
|
PBX homeobox 1 | 0.534 | 0.846 | 1.00 |
|
phenotype | 0.070 | None | 0.857 | 7 | 0 | 1991 | 2019 | ||||||||
|
T cell receptor gamma constant 1 | 0.663 | 0.385 |
|
phenotype | 0.090 | None | 0.889 | 9 | 0 | 1998 | 2012 | |||||||||
|
TCR gamma alternate reading frame protein | 0.638 | 0.500 |
|
phenotype | 0.090 | None | 0.889 | 9 | 0 | 1998 | 2012 | |||||||||
|
T cell receptor gamma locus | 0.631 | 0.538 |
|
phenotype | 0.100 | None | 0.900 | 10 | 0 | 1998 | 2012 | |||||||||
|
preferentially expressed antigen in melanoma | 0.531 | 0.577 | 2.4E-07 |
|
phenotype | 0.100 | None | 0.900 | 10 | 0 | 2001 | 2016 | ||||||||
|
fms related receptor tyrosine kinase 3 | 0.462 | 0.654 | 0.61 |
|
phenotype | 0.100 | None | 0.946 | 37 | 0 | 2001 | 2020 | ||||||||
|
immunoglobulin heavy locus | 0.473 | 0.654 |
|
phenotype | 0.100 | None | 0.949 | 39 | 0 | 1993 | 2019 | |||||||||
|
BCL2 apoptosis regulator | 0.291 | 0.885 | 0.56 |
|
phenotype | 0.100 | None | 0.952 | 20 | 0 | 1997 | 2020 | ||||||||
|
RUNX family transcription factor 1 | 0.425 | 0.808 | 0.65 |
|
phenotype | 0.100 | None | 0.953 | 43 | 0 | 1993 | 2019 | ||||||||
|
T cell receptor beta variable 20/OR9-2 (non-functional) | 0.403 | 0.923 |
|
phenotype | 0.100 | None | 0.954 | 65 | 0 | 1991 | 2020 | |||||||||
|
ETS variant transcription factor 6 | 0.477 | 0.731 | 0.97 |
|
phenotype | 0.100 | None | 0.962 | 26 | 0 | 1996 | 2019 | ||||||||
|
lysine methyltransferase 2A | 0.410 | 0.885 | 1.00 |
|
phenotype | 0.100 | None | 0.962 | 25 | 0 | 1996 | 2018 | ||||||||
|
RUNX1 partner transcriptional co-repressor 1 | 0.530 | 0.808 | 0.98 |
|
phenotype | 0.100 | None | 0.966 | 29 | 0 | 1993 | 2019 | ||||||||
|
nucleophosmin 1 | 0.464 | 0.846 | 1.00 |
|
phenotype | 0.100 | None | 0.978 | 46 | 0 | 2005 | 2020 |